These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. Li H; Liu Z; Ge J J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516 [TBL] [Abstract][Full Text] [Related]
3. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development. Samrat SK; Tharappel AM; Li Z; Li H Virus Res; 2020 Oct; 288():198141. PubMed ID: 32846196 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccine: A comprehensive status report. Kaur SP; Gupta V Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805 [TBL] [Abstract][Full Text] [Related]
5. A systematic review of SARS-CoV-2 vaccine candidates. Dong Y; Dai T; Wei Y; Zhang L; Zheng M; Zhou F Signal Transduct Target Ther; 2020 Oct; 5(1):237. PubMed ID: 33051445 [TBL] [Abstract][Full Text] [Related]
8. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108 [TBL] [Abstract][Full Text] [Related]
9. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2. Gupta SP Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Datta PK; Liu F; Fischer T; Rappaport J; Qin X Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005 [TBL] [Abstract][Full Text] [Related]
11. Overview of lethal human coronaviruses. Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance. Robson B Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687 [TBL] [Abstract][Full Text] [Related]
13. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561 [TBL] [Abstract][Full Text] [Related]
14. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Laczkó D; Hogan MJ; Toulmin SA; Hicks P; Lederer K; Gaudette BT; Castaño D; Amanat F; Muramatsu H; Oguin TH; Ojha A; Zhang L; Mu Z; Parks R; Manzoni TB; Roper B; Strohmeier S; Tombácz I; Arwood L; Nachbagauer R; Karikó K; Greenhouse J; Pessaint L; Porto M; Putman-Taylor T; Strasbaugh A; Campbell TA; Lin PJC; Tam YK; Sempowski GD; Farzan M; Choe H; Saunders KO; Haynes BF; Andersen H; Eisenlohr LC; Weissman D; Krammer F; Bates P; Allman D; Locci M; Pardi N Immunity; 2020 Oct; 53(4):724-732.e7. PubMed ID: 32783919 [TBL] [Abstract][Full Text] [Related]
15. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies. Papageorgiou AC; Mohsin I Cells; 2020 Oct; 9(11):. PubMed ID: 33105869 [TBL] [Abstract][Full Text] [Related]
16. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review. Giovane RA; Rezai S; Cleland E; Henderson CE Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275 [TBL] [Abstract][Full Text] [Related]